Cytokine production in haemodiafiltration: A multicentre study

Nephrology Dialysis Transplantation

Volumn 13, Issue 7, 1998, Pages 1737-1744

  Panichi, Vincenzo ^a   De Pietro, Stefano ^a   Andreini, Brunella ^a   Migliori, Massimiliano ^a   Tessore, Vincenzo ^c   Taccola, Daniele ^a   Rindi, Paolo ^b   Palla, Roberto ^a   Tetta, Ciro ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Cyberonics Inc   (Italy)

Author keywords

Backfiltration; Biocompatibility; Dialysate sterility; Haemodialysis (chronic complications); Haemodialysis membranes

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; POLYMYXIN B;

ADULT; AGED; ARTICLE; BACTERIUM CONTAMINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIALYSATE; HEMOFILTRATION; HUMAN; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGED; CYTOKINES; GRAM-NEGATIVE BACTERIA; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MIDDLE AGED; PYROGENS; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; TIME FACTORS;

EID: 0031749863     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.7.1737     Document Type: Article

References (45)

1. Harding GB, Klein E, Pass T et al. Endotoxin and bacterial contamination of dialysis centre water and dialysate. A cross sectional survey. Int J Artif Organs 1990; 13: 39-4
2. Bambauer R, Walther J, Meyer S et al. Bacteria-and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 1994; 18: 188-192
3. Bland LA, Favero MS. Microbiologic Aspects of Haemodialysis Systems. Association for the Advancement of Medical Instruments, Arlington, VA, 1993; 3: 257-265
4. Gordon SM, Oetlinger CW, Bland LA et al. Pyrogenic reactions in patients receiving conventional high-efficiency or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 1992; 2: 1436-1444
5. Tokars JI, Alter MJ, Favero MS, Moyer LA, Bland LA. National surveillance of hemodialysis associated diseases in the United States. ASAIO J 1990; 39: 71-80
6. Dinarello CA. Cytokines: agents provocateurs in hemodialysis. Kidney Int 1992; 41: 683-694
7. Lonnemann G. Dialysate bacteriological quality and the permeability of dialyser membranes to pyrogens. Kidney Int 1993; 43 [Suppl 41]: S195-S200
8. Pereira BJG Cytokine production in patients on dialysis. Blood Purif 1995; 13: 135-146
9. Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93: 527-617
10. Laude-Sharp M, Haeffner-Cavaillon N, Caroff M et al. Dissociation between the interleukin-1-inducing capacity and Limulus reactivity of lipopolysaccharides from Gram-negative bacteria. Cytokine 1990; 2 [Suppl 4]: 253-258
11. Pereira BJG, Snodgrass B, King AJ, Hogan P. Diffusive and convective transfer of cytokine-inducing bacterial products across haemodialysis membranes. Kidney Int 1995; 47: 603-610
12. Evans RC, Holmes CJ. In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes. Blood Purif. 1991; 9: 92-101
13. Lonnemann G, Koch KL. Replacement of renal function by dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, ed. Replacement of Renal Function by Dialysis, 4 edn. Kluwer, Dordrecht, 1996; 726 733
14. Bommer J, Becker KP, Urbaschek. Potential transfer of endotoxin across high-flux polysulfone membranes. JASN 1996; 7: 883-888
15. Lonnemann G, Behme TC, Lenzner B et al. Permeability of dialyser membranes to TNFα-inducing substances derived from water bacteria. Kidney Int 1992; 42: 61-68
16. Schindler R, Krautzig S, Lufft V et al. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. Nephrol Dial Transplant 1996; 11: 101-108
17. David S, Tetta C, Canino F et al. Production of platelet-activating factor by human neutrophils after backfiltration of endotoxin-contaminated dialysate. ASAIO J 1993; 39: M773-M777
18. Cappelli G, Tetta C, Cornia F et al. Removal of Limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 1993; 8: 1133-1139
19. Dinarello CA, Lonnemann G, Maxwell R et al. Ultrafiltration to reject human interleukin-1 inducing substances derived from bacterial cultures. J Clin Microbiol 1987; July: 1233-1238
20. Schindler R, Dinarello CA. A method for removing interleukin-1-and tumor necrosis factor-inducing substances form bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods 1989; 116: 159-165
21. Bambauer R, Walther J, Meyer S et al. Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis. Artif Organs 1994; 18[Suppl 4]: 188 192
22. Grooteman MPC, Nubé MJ, Daha MR et al. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol 1997; 8: 1745 1754
23. Ronco C, Feriani M, Brendolan S et al. Paired filtration dialysis. Studies on efficiency, flow dynamics and hydraulic properties of the system. Blood Purif 1990; 8: 126-140
24. Tetta C, Tropea F, Camussi G et al. Adherence of human monocytes to haemodialysis membranes: LFA1 (CD11a/CD18), CR1 (CD35) and CR3 (CD 11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence. Nephrol Dial Transplant 1995; 10: 1679-1688
25. Duff GW, Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods 1982; 52: 333-334
26. Lundberg L, Stegmayr BG, Wehle B. Backdiffusion or bicarbonate may stimulate complement activation during hemodialysis with low-flux membranes. Int J Artif Organs 1994; 17 [Suppl 3]: 131-136
27. Bigazzi R, Atti M, Baldari G. High-permeable membranes and hypersensitivity-like reactions. Role of dialysis fluid contamination. Blood Purif 1990; 8: 190-198
28. Smollich BP, Falkenhagen D, Schnewidewind J et al. Importance of endotoxinsin high-flux dialysis. Nephrol Dial Transplant 1991; [Suppl 3]: 83-85
29. Vanholder R, Van Haecke E, Veys N et al. Endotoxin transfer through dialysis membranes. small- versus large-pore membranes. Nephrol Dial Transplant 1992; 7: 333-339
30. Yamagami S, Adachi T, Sigimura T et al. Detection of endotoxin antibody in long term dialysis patients. Int J Artif Organs 1990; 13: 205-210
31. Brian JG, Svetlozar N, Natov N et al. Impact of single use versus reuse of cellulose dialysers on clinical parameters and indices of biocompatibility. JASN 1996; 7: 861-870
32. Ghezzi PM, Frigato G, Fantini GF et al. Theoretical model and first clinical results of the paired filtration dialysis. Life Support Sys 1983: [Suppl 1]: 271-278
33. Tielemans C, Husson C, Schurmans T et al. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro haemodialysis. Kidney Int 1996; 49: 236-243
34. Jorres A, Froese P, Fischer C et al. Variables associated with the assessment of systemic tumor necrosis factor alpha levels during haemodialysis. Int J Artif Organs 1992; 15 [Suppl 11]: 653-657
35. Pereira BJ. Implications of cytokine measurements during in vitro and clinical haemodialysis. Nephrol Dial Transplant 1995; 10 [Suppl 10]: 18-26
36. Endres S, Cannon JG, Ghorbani R et al. In vitro production of IL-1β, IL-x, TNF, and IL-2 in healthy subjects, distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 2327-2333
37. Poutsiaka DD, Clark BD, Vannier E et al. Production of interleukin-1 receptor antagonist and interleukin-1β by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78: 1275-1281
38. Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987; 139: 4129-4134
39. Engelman H, Aderka D, Rubinstein M et al. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264: 11974
40. Novick D, Engelmann H, Wallach D et al. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409
41. Tiku K, Tiku ML, Liu S et al. Normal human neutrophils are a source of a specific interleukin 1 inhibitor. J Immunol 1986; 136: 3686-3692
42. Schindler R, Lonnemann G, Schaffer J et al. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 1994; 68: 229-233
43. Pereira BJG, Poutsiaka DD, King AJ et al. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 1992; 42: 1419-1424
44. Poutsiaka DD, Clark BD, Vannier E et al. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 1991; 78: 1275-1281
45. Ridker PM, Cushman M, Stamfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979